Similar articles for PMID: 21301780

Year	Number of Results
1995	1
1999	1
2000	1
2002	1
2003	1
2004	1
2005	2
2006	8
2007	11
2008	11
2009	9
2010	4
2011	9
2012	4
2013	4
2014	8
2015	10
2016	5
2017	6
2018	5
2019	2
2020	1
2021	4
2022	4
2023	3
2024	0

1

Long-term secondary prophylaxis in children, adolescents and young adults with von Willebrand disease. Results of a cohort study.

Halimeh S, Krümpel A, Rott H, Bogdanova N, Budde U, Manner D, Faeser B, Mesters R, Nowak-Göttl U. Halimeh S, et al. Thromb Haemost. 2011 Apr;105(4):597-604. doi: 10.1160/TH10-09-0616. Epub 2011 Feb 8. Thromb Haemost. 2011. PMID: 21301780

2

The pharmacokinetic diversity of two von Willebrand factor (VWF)/ factor VIII (FVIII) concentrates in subjects with congenital von Willebrand disease. Results from a prospective, randomised crossover study.

Kessler CM, Friedman K, Schwartz BA, Gill JC, Powell JS; Wilate PK Study Investigators. Kessler CM, et al. Thromb Haemost. 2011 Aug;106(2):279-88. doi: 10.1160/TH11-02-0057. Epub 2011 Jul 4. Thromb Haemost. 2011. PMID: 21725579 Clinical Trial.

3

Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: ristocetin cofactor unit dosing in patients with von Willebrand disease.

Lillicrap D, Poon MC, Walker I, Xie F, Schwartz BA; Association of Hemophilia Clinic Directors of Canada. Lillicrap D, et al. Thromb Haemost. 2002 Feb;87(2):224-30. Thromb Haemost. 2002. PMID: 11858481

4

A phase III study comparing secondary long-term prophylaxis versus on-demand treatment with vWF/FVIII concentrates in severe inherited von Willebrand disease.

Peyvandi F, Castaman G, Gresele P, De Cristofaro R, Schinco P, Bertomoro A, Morfini M, Gamba G, Barillari G, Jiménez-Yuste V, Königs C, Iorio A, Federici AB. Peyvandi F, et al. Blood Transfus. 2019 Sep;17(5):391-398. doi: 10.2450/2019.0183-18. Epub 2019 Feb 4. Blood Transfus. 2019. PMID: 30747707 Free PMC article. Clinical Trial.

5

Clinical use of Haemate P in inherited von Willebrand's disease: a cohort study on 100 Italian patients.

Federici AB, Castaman G, Franchini M, Morfini M, Zanon E, Coppola A, Tagliaferri A, Boeri E, Mazzucconi MG, Rossetti G, Mannucci PM. Federici AB, et al. Haematologica. 2007 Jul;92(7):944-51. doi: 10.3324/haematol.11124. Haematologica. 2007. PMID: 17606445 Free article.

6

Efficacy and safety of a new generation von Willebrand factor/factor VIII concentrate (Wilate®) in the management of perioperative haemostasis in von Willebrand disease patients undergoing surgery.

Windyga J, von Depka-Prondzinski M; European Wilate® Study Group. Windyga J, et al. Thromb Haemost. 2011 Jun;105(6):1072-9. doi: 10.1160/TH10-10-0631. Epub 2011 Mar 24. Thromb Haemost. 2011. PMID: 21437358 Clinical Trial.

7

Safety and efficacy of a von Willebrand factor/factor VIII concentrate (Wilate®): a single centre experience.

Batty P, Chen YH, Bowles L, Hart DP, Platton S, Pasi KJ. Batty P, et al. Haemophilia. 2014 Nov;20(6):846-53. doi: 10.1111/hae.12496. Epub 2014 Aug 7. Haemophilia. 2014. PMID: 25102895

8

Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate.

Berntorp E, Windyga J; European Wilate Study Group. Berntorp E, et al. Haemophilia. 2009 Jan;15(1):122-30. doi: 10.1111/j.1365-2516.2008.01901.x. Haemophilia. 2009. PMID: 19149848 Clinical Trial.

9

Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.

Michiels JJ, van Vliet HH, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van der Velden A, Budde U. Michiels JJ, et al. Clin Appl Thromb Hemost. 2007 Jan;13(1):14-34. doi: 10.1177/1076029606296399. Clin Appl Thromb Hemost. 2007. PMID: 17164493 Free article. Review.

10

von Willebrand factor/factor VIII concentrate (Humate-P) for management of elective surgery in adults and children with von Willebrand disease.

Gill JC, Shapiro A, Valentino LA, Bernstein J, Friedman C, Nichols WL, Manco-Johnson M. Gill JC, et al. Haemophilia. 2011 Nov;17(6):895-905. doi: 10.1111/j.1365-2516.2011.02534.x. Epub 2011 Apr 27. Haemophilia. 2011. PMID: 21535320 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

99 results

Results by year